首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 31 毫秒
1.
《Federal register》1998,63(136):38414-38415
HCFA is adding three additional routine uses to the Systems of Records specified in Appendix A. These routine uses will permit HCFA to disclose individual-specific information for the purpose of combating fraud or abuse in the health benefit programs administered by HCFA and for other compatible purposes. These new routine uses will permit HCFA to make disclosures as follows: (1) To a HCFA contractor, including but not necessarily limited to fiscal intermediaries and carriers under title XVIII of the Social Security Act, to administer some aspect of a HCFA-administered health benefits program, or to a grantee of a HCFA-administered grant program, which program is or could be affected by fraud or abuse, for the purpose of preventing, deterring, discovering, detecting, investigating, examining, prosecuting, suing with respect to, defending against, correcting, remedying, or otherwise combating such fraud or abuse in such program; (2) To another Federal agency or to an instrumentality of any governmental jurisdiction within or under the control of the United States, including any state or local government agency, for the purpose of preventing, deterring, discovering, detecting, investigating, examining, prosecuting, suing with respect to, defending against, correcting, remedying, or otherwise combating fraud or abuse in a health benefits program funded in whole or in part by Federal funds; and, (3) To any entity that makes payment for or oversees the administration of health care services, for the purpose of preventing, deterring, discovering, detecting, investigating, examining, prosecuting, suing with respect to, defending against, correcting, remedying, or otherwise combating fraud or abuse against such entity or the program or services administered by such entity, subject to certain conditions.  相似文献   

2.
《Federal register》1984,49(180):36326-36351
The Food and Drug Administration (FDA) is issuing a final rule that requires manufacturers and importers of medical devices, including diagnostic devices, to report to FDA whenever the manufacturer or importer receives or otherwise becomes aware of information that reasonably suggests that one of its marketed devices (1) may have caused or contributed to a death or serious injury or (2) has malfunctioned and that the device or any other device marketed by the manufacturer or importer would be likely to cause or contribute to a death or serious injury if the malfunction were to recur. FDA is taking this action under the Medical Device Amendments of 1976. The final rule is intended to assure that FDA is informed promptly of all serious problems or potentially serious problems associated with marketed devices. FDA is the principal public health agency responsible for ensuring that devices are safe and effective. To carry out its responsibilities, the agency needs to be informed whenever a manufacturer or importer receives or otherwise becomes aware of information about device problems. Only if FDA is provided with such information will it be able to evaluate the risk, if any, associated with a device and take whatever action is necessary to reduce or eliminate the public's exposure to this risk. Depending on the facts and circumstances, these steps could include contacting the manufacturer or importer of the device and monitoring its voluntary actions to respond to the problem, initiating a consumer or user education program, or initiating regulatory action, such as injunction, seizure, or other enforcement action.  相似文献   

3.
《Federal register》1998,63(163):45004-45007
This document amends the Department of Veterans Affairs (VA) adjudication regulations concerning awards of compensation or dependency and indemnity compensation for additional disability or death due to VA hospital care, medical or surgical treatment, examination, or training and rehabilitation services. Under this final rule, benefits are payable for additional disability or death caused by VA hospital care, medical or surgical treatment, or examination only if VA fault or "an event not reasonably foreseeable" proximately caused the disability or death. Benefits are also payable for additional disability or death proximately caused by VA's provision of training and rehabilitation services. This final rule is necessary to reflect Congress' recent amendment of 38 U.S.C. 1151, the statutory authority for such benefits.  相似文献   

4.
《Federal register》1983,48(104):24014-24024
The Food and Drug Administration (FDA) is issuing a revised proposal to require manufacturers and importers of medical devices to report to FDA whenever the manufacturer or importer has information that reasonably suggests, or a person alleges and the manufacturer or importer is aware of the allegation, that a device has caused or contributed to a death or serious injury or that a device has malfunctioned, if a recurrence of the malfunction is likely to cause or contribute to a death or serious injury. After FDA analyzes the results of its manufacturer complaint file inspection program, the agency will consider whether any reports in addition to those proposed in this rule are necessary and, if so, will propose additional reporting requirements.  相似文献   

5.
《Federal register》1991,56(167):42532-42538
This final rule implements section 428(a) of Public Law 100-360 which authorizes the imposition of civil money penalties for the use--in advertising, solicitations or other communications--of certain words, letters, symbols or emblems associated with the Department of Health and Human Services' Social Security and Medicare programs in a manner that the user knows, or should know, would convey a false impression that (1) the communicated item was approved, endorsed or authorized by the Department or its programs, or (2) the responsible person or organization has some connection with, or authorization from, the Department or these programs. This rulemaking is designed to assist in protecting citizens from misrepresentations concerning the services offered and programs administered by the Social Security Administration and the Health Care Financing Administration.  相似文献   

6.
在损害赔偿法中,替代交易是一种有效的计算期望损害赔偿的方法,其已经得到各国国内立法以及国际条约或示范法文本的支持。替代交易相对于传统的期望赔偿或实际履行有独特的理论优势和操作性便利,如接近合同履行后的地位、增加确定性、阻止或最小化间接损失的社会成本、有效分配市场风险等等。替代交易的构成体现为实体要素和程序要素,其中实体要素中合理性最为重要,实践中有必要将替代交易分为搜寻和实际选择两个阶段,而且替代交易无需经由法院或非诉讼程序。替代交易是一种任意性救济方式,只适用于不履行的情况,同时在其适用上不限于商事交易和货物交易等。我国未来的合同法修改应当将替代交易予以制度化,以使期望损害赔偿更具现实力,实现合同救济的目的。  相似文献   

7.
张开骏 《北方法学》2017,11(2):86-97
聚众哄抢财物行为通常成立聚众哄抢罪;哄抢使用中厂房的物资设备的,是聚众哄抢罪与破坏生产经营罪的想象竞合犯,以聚众哄抢罪定罪处罚;聚众是与哄抢并列的行为或者是哄抢行为的方式或状态,说明了聚众哄抢罪的必要共同犯罪特征;成立聚众哄抢罪未必要有首要分子组织、策划或纠集;聚众哄抢罪的对象是他人占有的动产或者不动产中可以分离的部分;哄抢的本质是公然抢夺或盗窃;不符合聚众哄抢罪的哄抢财物行为可认定为抢夺罪或盗窃罪;聚众哄抢罪与抢夺罪、盗窃罪的共犯有差异;哄抢人采取对人暴力或胁迫等方式,压制被害人反抗而哄抢财物的成立抢劫罪,聚众哄抢罪可以成立事后抢劫;聚众"打砸抢"是聚众实施某些寻衅滋事行为的特别规定;"致人伤残、死亡"应限制解释为聚众"打砸"人所致;"毁坏或者抢走公私财物"是抢劫罪的法律拟制,首要分子以外的人成立寻衅滋事罪(或与敲诈勒索罪、聚众哄抢罪、故意毁坏财物罪等的想象竞合犯)。  相似文献   

8.
Participants who were more inclined to consider ambiguous work elements as inputs (input-oriented or Type-I persons) or as outcomes (outcome-oriented or Type-O persons) were presented with situations in which they had delivered a higher or lower work performance than another person. They were asked to take money for themselves, give money to the other person, and divide a fixed sum of money between themselves and the other as reward for the performances. The specific combination of (input or outcome) orientation of the participant and the type of transfer (giving, taking, or dividing) determined the reward the participant allocated to him- or herself and/or to the other person. Type-I persons showed an egocentric bias in their allocation behavior, whereas Type-O persons allocated according to a maximin strategy.  相似文献   

9.
修理、更换、回收利用是否构成专利权侵害   总被引:1,自引:0,他引:1  
李扬 《法律科学》2008,26(6):78-88
对专利产品进行修理、零部件更换或者回收利用是否构成专利权侵害,必须以专利权利要求保护的范围作为最基本的判断标准;即使对专利产品进行修理、零部件更换或者回收利用构成再造,也并不必然侵害专利权;在处理对专利产品进行修理、零部件更换或者回收利用是否专利权侵害的问题时,关键是处理好以生产经营为目的提供零部件的行为是否构成专利权间接侵害。  相似文献   

10.
包冰锋 《证据科学》2013,(6):676-685
证明妨碍是指当事人因可归责于对方当事人或第三人诉讼中或诉讼外、故意或过失的作为或不作为,致使自己的证明行为陷入困难或不能。构成证明妨碍的客观要件相对较为复杂,而且在实体法和程序法中均有规定。不论是诉讼前或诉讼中的作为或不作为,均可以构成证明妨碍行为。证明妨碍行为的结果,应当达到当事人证明不能或证明困难而使案件事实无法查明的状态。而且,证明妨碍行为与待证事实证明不能或证明困难的状态之间应当具有因果联系。  相似文献   

11.
12.
刑罚权配置和运作的正当性,应从个体性权利出发进行分析和论证。刑罚的适用即意味着自然人或者单位重大权利的剥夺或者限制,而这类权利应否被剥夺或者限制以及在何种程度上被剥夺或者限制,应通过这类权利的性质来认识和分析。在犯罪设置、刑罚制度方面,都应从个体性权利视角来检验制度、规范和解释结论的正当性。  相似文献   

13.
论禁止歧视   总被引:12,自引:0,他引:12  
周伟 《现代法学》2006,28(5):68-75
歧视是指被法律禁止的、针对特定群体或个人实施的、其效果或目的在于对承认、享有和行使基本权利进行区别、排斥、限制或优待的任何不合理的措施,即歧视的表现形式是在相同的情况下无合理理由而恣意取消或损害特定群体或个人平等享有权利的任何区分、排除或选择的措施。法律禁止歧视的目的是对少数群体或具备该群体特征的个人基本权利的保护以实现法律的公正。禁止歧视与平等在本质上是一致的,因为平等并不反对任何差别,但却反对没有合理依据的区别对待。如果差别有正当的理由并且是为了实现合法目的,则不构成歧视而是法律许可的合理差别。  相似文献   

14.
Government civil antitrust enforcement and private antitrust litigation are not always easy to avoid, because even innocent actions can be alleged to have been improperly motivated or to adversely affect competition. On the other hand, criminal antitrust violations can be readily avoided by following a set of basic, simple, and easy to remember rules: 1. Providers should not agree with competing or potentially competing providers on any terms of price, quantity, or quality of service; 2. Providers should not agree with competing or potentially competing providers as to which patients (or payors) will be served, what kinds of services will be offered, or where to locate offices or facilities; and 3. Providers should not agree with competing or potentially competing providers to refuse to offer services to payors or other alternative delivery systems. There are circumstances in which exceptions to these general rules are appropriate, such as when an agreement among providers is necessary in order to participate in a legitimate alternative delivery system, preferred provider organization, or individual practice association. However, these exceptions are narrow and technical. The best advice is the following warning to providers by Charles F. Rule, former U.S. Assistant Attorney General for antitrust: "You should never act as if an exception applies until after you have consulted an experienced antitrust lawyer or until you have obtained adequate assurance that competent counsel has structured the system to eliminate antitrust problems."  相似文献   

15.
The Medicaid Integrity Program (the Program) provides that the Secretary promote the integrity of the Medicaid program by entering into contracts with contractors that will review the actions of individuals or entities furnishing items or services (whether fee-for-service, risk, or other basis) for which payment may be made under an approved State plan and/or any waiver of the plan approved under section 1115 of the Social Security Act; audit claims for payment of items or services furnished, or administrative services furnished, under a State plan; identify overpayments of individuals or entities receiving Federal funds; and educate providers of services, managed care entities, beneficiaries, and other individuals with respect to payment integrity and quality of care. This final rule will provide for limitations on a contractor's liability while performing these services under the Program. The final rule will, to the extent possible, employ the same or comparable standards and other substantive and procedural provisions as are contained in section 1157 (Limitation on Liability) of the Social Security Act.  相似文献   

16.
论公司、企业人员受贿罪的客观特征   总被引:1,自引:0,他引:1  
黄明儒 《时代法学》2003,1(2):47-51
1997年刑法对公司、企业人员受贿罪的修订影响了对该罪内涵意义的理解 ,特别是需要重新考察其客观要件。公司、企业人员受贿罪既侵犯了公司、企业经营活动的公正竞争交易秩序 ,又侵犯了公司、企业工作人员的廉洁性。该罪在客观方面表现为公司、企业的工作人员 ,利用职务上的便利 ,索取他人财物或者非法收受他人财物 ,为他人谋取利益 ,或者在经济往来中 ,违反国家规定收受各种名义的回扣、手续费 ,归个人所有 ,数额较大的行为  相似文献   

17.
自由贸易区的法律思考:模式、依据及框架   总被引:1,自引:0,他引:1  
自由贸易区有单边及双边或多边两种模式,而双边或多边自由贸易区在理论上又可分为一般意义的双边或多边自由贸易区及次级双边或多边自由贸易区两种。就国际经贸规则而言,建立单边自由贸易区及双边或多边自由贸易区的法律依据不仅充分而且成熟,但在次级双边或多边自由贸易区的合法性问题上,则存在较大争议。此外,为因应当前经济全球化浪潮汹涌的新形势,借鉴其他国家及地区的经验,构建完善的单边自由贸易区法律应是值得探讨的问题。  相似文献   

18.
住宅小区车位、车库具有构造上、使用上和法律上的独立性,在性质上属于建筑物区分所有权的专有部分,可以成为建筑物区分所有权的客体。不能依车位、车库的建筑面积是否计入商品房的公摊面积或者车位、车库的建造成本是否摊入住宅开发成本来判断车位、车库的权利归属,也不能依开发商与业主之间的约定来确定车位、车库的权利归属。车位、车库应由业主法定地共有。  相似文献   

19.
《Federal register》1990,55(189):39730-39739
This notice describes the criteria and standards to be used for evaluating the performance of fiscal intermediaries and carriers in the administration of the Medicare program beginning October 1, 1990. The results of these evaluations are considered whenever HCFA enters into, renews, or terminates an intermediary agreement or carrier contract or takes other contract actions; assigns or reassigns providers of services to an intermediary; or designates regional or national intermediaries. This notice is published in accordance with sections 1816(f) and 1842(b)(2) of the Social Security Act, which requires us to publish for public comment in the Federal Register those criteria and standards against which we evaluate intermediaries and carriers.  相似文献   

20.
《Federal register》1990,55(85):18391-18400
This notice describes the criteria and standards to be used for evaluating the performance of fiscal intermediaries and carriers in the administration of the Medicare program beginning June 1, 1990. The results of these evaluations are considered whenever HCFA enters into, renews, or terminates an intermediary or carrier agreement or takes other contract actions; assigns or reassigns providers of services to an intermediary; or designates regional or national intermediaries. This notice is published in accordance with sections 1816(f) and 1842(b)(2) of the Social Security Act, which requires us to publish for public comment in the Federal Register those criteria and standards against which we evaluate intermediaries and carriers.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号